Cornerstone Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.89M | Sell |
15,584
-22
| -0.1% | -$4.08K | 0.31% | 54 |
|
2025
Q1 | $2.92M | Sell |
15,606
-210
| -1% | -$39.3K | 0.34% | 53 |
|
2024
Q4 | $3.05M | Buy |
15,816
+230
| +1% | +$44.4K | 0.35% | 53 |
|
2024
Q3 | $3.08M | Sell |
15,586
-401
| -3% | -$79.2K | 0.41% | 52 |
|
2024
Q2 | $2.74M | Sell |
15,987
-5,137
| -24% | -$881K | 0.39% | 52 |
|
2024
Q1 | $3.85M | Buy |
21,124
+16
| +0.1% | +$2.91K | 0.55% | 44 |
|
2023
Q4 | $3.27M | Buy |
21,108
+795
| +4% | +$123K | 0.51% | 44 |
|
2023
Q3 | $3.03M | Buy |
20,313
+94
| +0.5% | +$14K | 0.53% | 40 |
|
2023
Q2 | $2.72M | Sell |
20,219
-244
| -1% | -$32.9K | 0.48% | 42 |
|
2023
Q1 | $3.26M | Buy |
20,463
+1,798
| +10% | +$287K | 0.59% | 34 |
|
2022
Q4 | $3.02M | Sell |
18,665
-1,495
| -7% | -$242K | 0.59% | 36 |
|
2022
Q3 | $2.71M | Buy |
20,160
+2,281
| +13% | +$306K | 0.6% | 34 |
|
2022
Q2 | $2.74M | Sell |
17,879
-14,850
| -45% | -$2.27M | 0.63% | 34 |
|
2022
Q1 | $5.31M | Sell |
32,729
-6
| -0% | -$973 | 0.81% | 26 |
|
2021
Q4 | $4.43M | Sell |
32,735
-73
| -0.2% | -$9.89K | 0.64% | 30 |
|
2021
Q3 | $3.54M | Sell |
32,808
-619
| -2% | -$66.8K | 0.59% | 35 |
|
2021
Q2 | $3.77M | Buy |
33,427
+3,384
| +11% | +$381K | 0.63% | 35 |
|
2021
Q1 | $3.25M | Sell |
30,043
-1,881
| -6% | -$204K | 0.62% | 35 |
|
2020
Q4 | $3.42M | Buy |
31,924
+1,271
| +4% | +$136K | 0.69% | 36 |
|
2020
Q3 | $2.69M | Buy |
30,653
+19,374
| +172% | +$1.7M | 0.63% | 41 |
|
2020
Q2 | $1.11M | Buy |
11,279
+5,927
| +111% | +$582K | 0.29% | 65 |
|
2020
Q1 | $408K | Buy |
+5,352
| New | +$408K | 0.12% | 104 |
|